PHILADELPHIA, Nov. 20, 2013 /PRNewswire/ -- Applied Clinical Intelligence has announced that it will begin doing business as ACI Clinical, effective January 1st 2014, to better reflect the organization's services related to Endpoint Adjudication Committees (EAC) and Data Monitoring Committees (DMC) in clinical research. With the adoption of its new name, logo and corporate offices, ACI Clinical has also launched a redesigned website: www.aciclinical.com
(Logo: http://photos.prnewswire.com/prnh/20131120/PH19940LOGO)
Having supported more than 600 projects for nearly 100 different clients, ACI is one of the most experienced providers of Endpoint Adjudication and DMCs. The company has supported more than 20 regulatory approved products and numerous publications. In the last few years alone, ACI has managed 100+ EACs and has introduced a unique risk-based model for DMCs to be more effective and cost-efficient for sponsors.
"This rebranding reflects the evolution of the organization over the past twelve years into a leading provider of independent committee management solutions," said Jonathan Seltzer, President and CEO of ACI Clinical. "Study endpoints are often the most important aspect of the data, and they require special expertise. Our team openly and honestly advises clients on the best route to success – whether it be an independent committee, no committee at all, or a risk-based approach to save unnecessary costs."
In addition to full service independent committee solutions, for which ACI Clinical maintains an extensive global network of pre-vetted clinical and statistical experts, the company also continues to provide robust data services and advisory services.
About ACI Clinical
ACI Clinical is a specialty service provider in clinical research that combines service excellence with regulatory and therapeutic expertise. ACI specializes in managing and facilitating Endpoint Adjudication Committees (EAC) and Data Monitoring Committees (DMC), with related data and advisory services, in order to enhance trial integrity and prepare data for publication, regulatory submission, and approval.
For More Information, Contact:
Amy Ghelardi
Marketing Director
Phone: 484-270-4251
[email protected]
SOURCE ACI Clinical
Share this article